Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
6
Genética
4
Condiciones económicas
3
Biología molecular
2
Campesinos
2
Condiciones sociales
2
Evolución (Biología)
2
Francia
2
Genética humana
2
ADN
1
Adaptación (Biología)
1
Administración
1
Agentes antineoplásicos
1
Agricultura
1
Agricultura y Estado
1
Algoritmos en informática
1
Algoritmos genéticos
1
América Latina
1
Aprendizaje colaborativo
1
Asociaciones
1
Aspectos económicos
1
Aspectos moleculares
1
Aspectos sociales
1
Aspectos sociológicos
1
Banano
1
Cambio social
1
Capitalismo
1
Civilización
1
Clubes
1
Condiciones rurales
1
-
195341por Liu, Fei, Zhou, Junping, Hu, Mengkai, Chen, Yan, Han, Jin, Pan, Xuewei, You, Jiajia, Xu, Meijuan, Yang, Taowei, Shao, Minglong, Zhang, Xian, Rao, Zhiming“…Whole-genome sequencing revealed multiple gene-mutations in STA, in combination with transcriptome analysis under R-MA stress condition, we identified five critical genes that were associated with R-MA tolerance, among which AcrA overexpression could further improve R-MA titer to 15.70 g/L, the highest titer reported from bulk styrene oxide substrate. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
195342por Isla, Dolores, Lopez-Brea, Marta, Espinosa, María, Arrabal, Natalia, Pérez-Parente, Diego, Carcedo, David, Bernabé-Caro, Reyes“…BACKGROUND: Atezolizumab has recently been approved for first-line treatment of high PD-L1 expression metastatic Non-Small-Cell Lung Cancer (NSCLC) patients with no EGFR or ALK mutations, on the basis of the IMpower110 trial. This study aims to estimate the cost-effectiveness of atezolizumab compared with pembrolizumab among these patients in Spanish settings, based on the results of the two cut-offs of the IMpower110 study. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
195343por Praus, Friederike, Künstner, Axel, Sauer, Thorben, Kohl, Michael, Kern, Katharina, Deichmann, Steffen, Végvári, Ákos, Keck, Tobias, Busch, Hauke, Habermann, Jens K., Gemoll, Timo“…METHODS: We analysed fresh-frozen tissue samples prepared under strict cryogenic conditions of matched healthy colon mucosa, colorectal carcinoma, and liver metastasis from the same patients. Somatic mutations of known cancer-related genes were analysed using Illumina's TruSeq Amplicon Cancer Panel; the transcriptome was assessed comprehensively using Clariom D microarrays. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
195344por Cetin, Meryem H., Rieckmann, Thorsten, Hoffer, Konstantin, Riepen, Britta, Christiansen, Sabrina, Gatzemeier, Fruzsina, Feyerabend, Simon, Schoof, Melanie, Schüller, Ulrich, Petersen, Cordula, Mynarek, Martin, Rothkamm, Kai, Kriegs, Malte, Struve, Nina“…BACKGROUND: The gene of the Epidermal growth factor receptor (EGFR) is one of the most frequently altered genes in glioblastoma (GBM), with deletions of exons 2–7 (EGFRvIII) being amongst the most common genomic mutations. EGFRvIII is heterogeneously expressed in GBM. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
195345“…BACKGROUND: Functional mutations or polymorphisms affecting forkhead box P3 (FOXP3) can lead to their abnormal FOXP3 gene expression and/or defective Treg cells generation, thus resulting in autoimmune disease and inflammatory disorders. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
195346por Yu, Hui, Shi, Xiao, Shao, Zhongmei, Geng, Hao, Guo, Senzhao, Li, Kuokuo, Gu, Meng, Xu, Chuan, Gao, Yang, Tan, Qing, Duan, Zongliu, Wu, Huan, Hua, Rong, Guo, Rui, Wei, Zhaolian, Zhou, Ping, Cao, Yunxia, He, Xiaojin, Li, Liang, Zhang, Xiaoping, Lv, Mingrong“…ICSI was applied to assist the mutational patient to achieve offspring. RESULT: We identified two HYDIN compound heterozygous variants. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
195347por Zheng, Xiaoming, Zhong, Limei, Pang, Hongbo, Wen, Siyu, Li, Fei, Lou, Danjing, Ge, Jinyue, Fan, Weiya, Wang, Tianyi, Han, Zhenyun, Qiao, Weihua, Pan, Xiaowu, Zhu, Yebao, Wang, Jilin, Tang, Cuifeng, Wang, Xinhua, Zhang, Jing, Xu, Zhijian, Kim, Sung Ryul, Kohli, Ajay, Ye, Guoyou, Olsen, Kenneth M., Fang, Wei, Yang, Qingwen“…BACKGROUND: DNA mutations of diverse types provide the raw material required for phenotypic variation and evolution. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
195348por Siegel, David A., Thanh, Cassandra, Wan, Eunice, Hoh, Rebecca, Hobbs, Kristen, Pan, Tony, Gibson, Erica A., Kroetz, Deanna L., Martin, Jeffrey, Hecht, Frederick, Pilcher, Christopher, Martin, Maureen, Carrington, Mary, Pillai, Satish, Busch, Michael P., Stone, Mars, Levy, Claire N., Huang, Meei-Li, Roychoudhury, Pavitra, Hladik, Florian, Jerome, Keith R., Kiem, Hans-Peter, Henrich, Timothy J., Deeks, Steven G., Lee, Sulggi A.“…RESULTS: Previously reported ‘protective’ host genetic mutations related to viral setpoint (e.g. among elite controllers) were found to predict smaller HIV reservoir size. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
195349por Helal, Duaa S., Darwish, Sara A., Awad, Radwa A., Ali, Dina A., El-Guindy, Dina M.“…Human epidermal growth factor receptor 2 (HER2) and epidermal growth factor receptor (EGFR) are mutated in multiple cancers including MIBC and are potential therapeutic targets. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
195350por Choi, Hyunwoo, Kim, Bo-Gyeong, Kim, Yong Hwan, Lee, Se-Jin, Lee, Young Jae, Oh, S. Paul“…Hereditary hemorrhagic telangiectasia (HHT) is a genetic vascular disorder characterized by the presence of arteriovenous malformation (AVM) in multiple organs. HHT is caused by mutations in genes encoding major constituents for transforming growth factor-β (TGF-β) family signaling: endoglin (ENG), activin receptor-like kinase 1 (ALK1), and SMAD4. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
195351por Zheng, Axiu, Bai, Jianrong, Ha, Yanping, Yu, Yaping, Fan, Yonghao, Liang, Meihua, Lu, Yanda, Shen, Zhihua, Luo, Botao, Jie, Wei“…Moreover, STON1 was positively associated with mismatch repair proteins and negatively correlated with tumor mutational burden. Furthermore, Single sample Gene Set Enrichment Analysis algorithm and Pearson analysis found that the low STON1 group was more sensitive to immune checkpoint blockage whereas the high STON1 group was relatively suitable for targeted treatment. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
195352por Hillmen, Peter, Eichhorst, Barbara, Brown, Jennifer R., Lamanna, Nicole, O'Brien, Susan M., Tam, Constantine S., Qiu, Lugui, Kazmierczak, Maciej, Zhou, Keshu, Šimkovič, Martin, Mayer, Jiří, Gillespie-Twardy, Amanda, Shadman, Mazyar, Ferrajoli, Alessandra, Ganly, Peter S., Weinkove, Robert, Grosicki, Sebastian, Mital, Andrzej, Robak, Tadeusz, Österborg, Anders, Yimer, Habte A., Salmi, Tommi, Ji, Meng, Yecies, Jessica, Idoine, Adam, Wu, Kenneth, Huang, Jane, Jurczak, Wojciech“…ORR was higher with zanubrutinib versus ibrutinib in subgroups with del(17p)/TP53 mutations (80.5% v 50.0%) and del(11q) (83.6% v 69.1%); 12-month progression-free survival in all patients was higher with zanubrutinib (94.9%) versus ibrutinib (84.0%; hazard ratio, 0.40; 95% CI, 0.23 to 0.69). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
195353por Alzua, Garazi Pena, Pihl, Anne Finne, Offersgaard, Anna, Duarte Hernandez, Carlos Rene, Duan, Zhe, Feng, Shan, Fahnøe, Ulrik, Sølund, Christina, Weis, Nina, Law, Mansun, Prentoe, Jannick C, Christensen, Jan Pravsgaard, Bukh, Jens, Gottwein, Judith Margarete“…DESIGN: High-yield genotype 1a, 2a and 3a HCV were developed by serial passage of TNcc, J6cc and DBN3acc in Huh7.5 cells and engineering of acquired mutations detected by next-generation sequencing. Neutralising epitope exposure was determined in cell-based neutralisation assays using human monoclonal antibodies AR3A and AR4A, and polyclonal antibody C211. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
195354por Zhong, Wen-Zhao, Yan, Hong-Hong, Chen, Ke-Neng, Chen, Chun, Gu, Chun-Dong, Wang, Jun, Yang, Xue-Ning, Mao, Wei-Min, Wang, Qun, Qiao, Gui-Bin, Cheng, Ying, Xu, Lin, Wang, Chang-Li, Chen, Ming-Wei, Kang, Xiao-Zheng, Yan, Wan-Pu, Liao, Ri-Qiang, Yang, Jin-Ji, Zhang, Xu-Chao, Liu, Si-Yang, Zhou, Qing, Wu, Yi-Long“…EMERGING-CTONG 1103 showed improved progression-free survival (PFS) with neoadjuvant erlotinib vs. chemotherapy for patients harbouring EGFR sensibility mutations and R0 resected stage IIIA-N2 non-small cell lung cancer (NSCLC) (NCT01407822). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
195355por Abdollahi, Nika, Jeusset, Lucile, de Septenville, Anne, Davi, Frederic, Bernardes, Juliana Silva“…This process, known as B cell affinity maturation, increases antibody affinity, forming a specific B cell lineage that includes the unmutated ancestor and mutated variants. In a B cell lineage, cells with a higher antigen affinity will undergo clonal expansion, while those with a lower affinity will not proliferate and probably be eliminated. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
195356por Sandouk, Aline, Xu, Zhen, Baruah, Sankar, Tremblay, Mikaela, Hopkins, Jesse B., Chakravarthy, Srinivas, Gakhar, Lokesh, Schnicker, Nicholas J., Houtman, Jon C. D.“…Our model is also validated by several novel full-length GRB2 mutants that favor either a monomeric or a dimeric state through mutations within the SH2 domain that abrogate or promote SH2/SH2 domain-swapping. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
195357por Graf, Ryon P., Fisher, Virginia, Creeden, James, Schrock, Alexa B., Ross, Jeffrey S., Nimeiri, Halla, Oxnard, Geoffrey R., Klempner, Samuel J.“…Patients with advanced gastroesophageal cancer (mEG) and tumor mutational burden ≥10 mut/Mb (TMB ≥ 10) have more favorable outcomes on immune checkpoint inhibitor (ICPI) monotherapy compared with chemotherapy in subgroup analyses of randomized controlled trials. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
195358por Ganie, Firdous, Mehfooz, Nazia, Siraj, Farhana, Khan, Umar H, Mantoo, Suhail, Dhar, Amrit, Mir, Mohmad Hussain, Jan, Rafi A, Shah, Sonaullah, Qadri, Syed Mudasir“…Other oncogenic driver mutations are not connected to PD-L1 expression. The function of PD-L1 expression in lung tumors requires more study.…”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
195359por Cai, DQ., Cai, Diankui, Zou, Yiping, Chen, Xumeng, Jian, Zhixiang, Shi, Mude, Lin, Ye, Chen, Jueming“…For genomic alterations, we revealed that mutations in PIK3CA, DMD, and APOB were more common in the cr-TILCD8Sig-high subgroup than in the cr-TILCD8Sig-low subgroup. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
195360por Adlhoch, Cornelia, Fusaro, Alice, Gonzales, José L, Kuiken, Thijs, Marangon, Stefano, Mirinaviciute, Grazina, Niqueux, Éric, Stahl, Karl, Staubach, Christoph, Terregino, Calogero, Broglia, Alessandro, Baldinelli, Francesca“…Although the virus retained a preferential binding for avian‐like receptors, several mutations associated to increased zoonotic potential were detected. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto